Abdulhameed Tomeh

Dr. Abdulhameed Tomeh

Universiti Putra Malaysia, Seri Kembangan, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ATAbdulhameed Tomeh
Abdulhameed Tomeh
AKAbdul Hanif Khan Yusof Khan
Abdul Hanif Khan Yusof Khan
LMLiyana Najwa Inche Mat
Liyana Najwa Inche Mat
HBHamidon Basri
Hamidon Basri
WSWan Aliaa Binti Wan Sulaiman
Wan Aliaa Binti Wan Sulaiman
Transcranial magnetic stimulation (TMS) has emerged as a novel technique to stimulate the human brain through the scalp. Over the years, identifying the optimal brain region and stimulation parameters has been a subject of debate in the literature on therapeutic uses of repetitive TMS (rTMS). Nevertheless, the primary motor cortex (M1) has been a conventional target for rTMS to treat motor symptoms, such as hemiplegia and spasticity, as it controls the voluntary movement of the body. However, with an expanding knowledge base of the M1 cortical and subcortical connections, M1-rTMS has shown a therapeutic efficacy that goes beyond the conventional motor rehabilitation to involve pain, headache, fatigue, dysphagia, speech and voice impairments, sleep disorders, cognitive dysfunction, disorders of consciousness, anxiety, depression, and bladder dysfunction. In this review, we summarize the latest evidence on using M1-rTMS to treat non-motor symptoms of diverse etiologies and discuss the potential mechanistic rationale behind the management of each of these symptoms.

21 March 2025 in Medicine
Verified
Journal Article
Open access
ATAbdulhameed Tomeh
Abdulhameed Tomeh
AKAbdul Hanif Khan Yusof Khan
Abdul Hanif Khan Yusof Khan
ZZZalina Abu Zaid
Zalina Abu Zaid
KLKing-Hwa Ling
King-Hwa Ling
LMLiyana Najwa Inche Mat
Liyana Najwa Inche Mat
WSWan Aliaa Binti Wan Sulaiman
Wan Aliaa Binti Wan Sulaiman
Collaboration among health and non-health professionals is growing exponentially as we approach the personalized medicine era, where the intervention plan is tailored according to the patient’s needs. This collaboration aims to develop highly efficient, patient-centered, holistic approaches, rather than singular interventions. Interdisciplinary rehabilitation is a rising theme to coordinate the efforts of various professionals, with the ultimate goal of increasing rehabilitants’ satisfaction and improving their overall quality of life. A typical rehabilitation team may comprise a rehabilitation physician, rehabilitation nurse, occupational therapist, physiotherapist, speech and language therapist, clinical psychologist, social worker, prosthetist, orthotist, rehabilitation engineer, and dietician. The need for inclusion of additional professions in the rehabilitation team is dynamic and varies depending on the population and health condition. Recently, various countries have begun incorporating interdisciplinary rehabilitation models into their healthcare frameworks. For example, the U.S. Veterans Affairs Polytrauma Rehabilitation Centers have set a precedent for integrating interdisciplinary approaches into neurological rehabilitation, while European nations such as Germany and Sweden have successfully implemented stroke and pain rehabilitation programs. Although interdisciplinary rehabilitation has demonstrated effectiveness in improving patient outcomes, further research is required to explore its long-term benefits, cost-effectiveness, and adaptability in resource-limited settings. In this mini-review, we summarize the current evidence on employing interdisciplinary rehabilitation in patients with neurological disorders and highlight the implications for future research and clinical practice.

13 March 2025 in IBRO Neuroscience Reports
Verified
Journal Article
Open access
ATAbdulhameed Tomeh
Abdulhameed Tomeh
AKAbdul Hanif Khan Yusof Khan
Abdul Hanif Khan Yusof Khan
ZZZalina Abu Zaid
Zalina Abu Zaid
KLKing-Hwa Ling
King-Hwa Ling
LMLiyana Najwa Inche Mat
Liyana Najwa Inche Mat
WSWan Aliaa Binti Wan Sulaiman
Wan Aliaa Binti Wan Sulaiman
Poor reproducibility and high inter-individual variability in responses to intermittent theta burst stimulation (iTBS) of the human motor cortex (M1) are matters of concern. Here we recruited 17 healthy young adults in a randomized, sham-controlled, crossover study. Transcranial magnetic stimulation (TMS)-elicited motor evoked potentials (MEPs) were measured pre-iTBS (T0) and post-iTBS at 4–7 (T1), 9–12 (T2), 17–20 (T3), and 27–30 minutes (T4) from the right first dorsal interosseous muscle. MEP grand average (MEPGA) was defined as the mean of the normalized-to-baseline MEPs at all timepoints post-iTBS. As secondary objectives, we measured blood pressure, heart rate, and capillary blood glucose pre-iTBS, and at 0 and 30 minutes post-iTBS. The TMSens_Q structured questionnaire was filled out at the end of each session. Two-way repeated ANOVA did not show a significant TIME×INTERVENTION interaction effect on MEP amplitude, MEP latency, blood pressure, heart rate, and blood glucose (p > 0.05). Sleepiness was the most reported TMSens_Q sensation (82.3 %) in both groups. Surprisingly, the subjects’ height negatively correlated with the normalized MEP amplitudes at T3 (r = -0.65, p = 0.005), T4 (r = -0.66, p = 0.004), and MEPGA (r = -0.68, p = 0.003), with a trend correlation at T1 (r = -0.46, p = 0.062) and T2 (r = -0.46, p = 0.065) in the active but not sham group. In view of this, we urge future studies to delve deeper into the influence of height on neuroplasticity induction of the M1 representation of peripheral muscles. In the end, we highlight unique methodological considerations in our study protocol and future recommendations for M1-iTBS studies.

13 September 2026 in medRxiv
Verified
Preprint
Open access
PDF file
ATAbdulhameed Tomeh
Abdulhameed Tomeh
AKAbdul Hanif Khan Yusof Khan
Abdul Hanif Khan Yusof Khan
ZZZalina Abu Zaid
Zalina Abu Zaid
KLKing-Hwa Ling
King-Hwa Ling
LMLiyana Najwa Inche Mat
Liyana Najwa Inche Mat
WSWan Aliaa Binti Wan Sulaiman
Wan Aliaa Binti Wan Sulaiman
Neurological and cardiovascular disorders frequently coexist, yet targeted dual-system interventions remain underinvestigated. Transcranial magnetic stimulation (TMS), including intermittent and continuous theta-burst stimulation (iTBS/cTBS), non-invasively modulates primary motor cortex (M1) excitability. Concurrently, ketone monoesters (KME) show neuroprotective potential and alter cardiovascular hemodynamics. In a randomized, double-blind, placebo-controlled crossover study, 44 healthy young adults were stratified to receive iTBS or cTBS (n = 22/group). Participants completed two sessions separated by 1 week, consuming either a KME or placebo beverage, followed by TBS 1-hour post-ingestion. Motor evoked potentials (MEPs) from the right first dorsal interosseous muscle were tracked for 30 minutes post-stimulation. Blood pressure was measured every 3-5 minutes, heart rate was monitored continuously, and venous blood was sampled for glucose, beta-hydroxybutyrate (BHB), pro-BDNF, mature BDNF (mBDNF), and the BDNF rs6265 polymorphism. We found that KME significantly elevated blood BHB and heart rate while decreasing blood glucose and diastolic blood pressure. KME did not alter resting motor threshold, baseline MEP amplitude, or MEP latency. Factorial analysis showed no significant modification of post-TBS MEP time courses by KME. In exploratory within-condition analyses, placebo-cTBS induced significant late increases in MEP amplitude, whereas KME-cTBS showed a blunted post-stimulation response. Serum mBDNF and pro-BDNF concentrations remained unchanged. In conclusion, combining KME and TBS is feasible, well-tolerated, and may exert concurrent neurological and cardiovascular effects. This work opens the door to a novel metabolic-neuromodulatory avenue that merits confirmation in larger cohorts and establishment of clinical relevance in patients with comorbid neurological and cardiovascular disorders.